Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension

Archives of Toxicology

Volumn 83, Issue 5, 2009, Pages 439-449

  Rizzi, Elen ^a   Castro, Michele M ^a   Fernandes, Karla ^a   Barbosa Jr , Fernando ^a   Arisi, Gabriel Maisonnave ^a   Garcia Cairasco, Norberto ^a   Bendhack, Lusiane M ^a   Tanus Santos, Jose E ^a   Gerlach, Raquel F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Doxycycline; Hypertension; Lead; MMP 2; Toxicity; Vascular dysfunction

Indexed keywords

DOXYCYCLINE; GELATINASE A; LEAD ACETATE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENE EXPRESSION; HISTOPATHOLOGY; HYPERTENSION; LEAD BLOOD LEVEL; LEAD POISONING; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; ENZYME INHIBITORS; GENE EXPRESSION; HYPERTENSION; LEAD; MALE; MATRIX METALLOPROTEINASE 2; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE STANDARDS; RNA, MESSENGER; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

RATTUS;

EID: 67349257950     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-008-0363-1     Document Type: Article

References (56)

1. P Altieri C Brunelli S Garibaldi A Nicolino S Ubaldi P Spallarossa L Olivotti P Rossettin A Barsotti G Ghigliotti 2003 Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure Eur J Clin Invest 33 648 656 (Pubitemid 36918626)
2. F Barbosa Jr RF Gerlach JE Tanus-Santos 2006 Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations Basic Clin Pharmacol Toxicol 98 559 564 (Pubitemid 43751561)
3. A Bernard R Lauwerys 1987 Metal-induced alterations of delta-aminolevulinic acid dehydratase Ann N Y Acad Sci 514 41 47 (Pubitemid 18097955)
4. S Blankenberg HJ Rupprecht O Poirier C Bickel M Smieja G Hafner J Meyer F Cambien L Tiret 2003 Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease Circulation 107 1579 1585 (Pubitemid 36397324)
5. Bouvet C, Gilbert LA, Girardot D, deBlois D, Moreau P (2005) Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition. Hypertension 45:432-437
6. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254
7. M Carmignani P Boscolo A Poma AR Volpe 1999 Kininergic system and arterial hypertension following chronic exposure to inorganic lead Immunopharmacology 44 105 110
8. M Carmignani AR Volpe P Boscolo N Qiao M Di Gioacchino A Grilli M Felaco 2000 Catcholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment Life Sci 68 401 415 (Pubitemid 32011893)
9. MM Castro E Rizzi RR Rascado S Nagassaki LM Bendhack JE Tanus-Santos 2004 Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms Eur J Pharmacol 498 189 194 (Pubitemid 39208078)
10. MM Castro E Rizzi L Figueiredo-Lopes K Fernandes LM Bendhack DL Pitol RF Gerlach JE Tanus-Santos 2008 Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats Atherosclerosis 198 320 321
11. E Courtois M Marques A Barrientos S Casado A Lopez-Farre 2003 Lead-induced downregulation of soluble guanylate cyclase in isolated rat aortic segments mediated by reactive oxygen species and cyclooxygenase-2 J Am Soc Nephrol 14 1464 1470 (Pubitemid 36687047)
12. Dao HH, Lemay J, de Champlain J, deBlois D, Moreau P (2001) Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. J Hypertens 19:1965-1973
13. Y Ding HC Gonick ND Vaziri 2000 Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells Am J Hypertens 13 552 555 (Pubitemid 30330720)
14. Y Ding HC Gonick ND Vaziri K Liang L Wei 2001 Lead-induced hypertension. III. Increased hydroxyl radical production Am J Hypertens 14 169 173 (Pubitemid 32171570)
15. JD Escolar C Tejero MA Escolar F Montalvo R Garisa 1997 Architecture, elastic fiber, and collagen in the distal air portion of the lung of the 18-month-old rat Anat Rec 248 63 69 (Pubitemid 27188379)
16. JD Escolar C Tejero MA Escolar F Montalvo R Garisa 1997 Methodological contributions for the morphometric study of the lung: approximation to the ideal sample size and quantification of collagen fiber Anat Rec 247 501 511 (Pubitemid 27157426)
17. C Fernandez-Patron MW Radomski ST Davidge 1999 Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor Circ Res 85 906 911 (Pubitemid 29534165)
18. C Fernandez-Patron KG Stewart Y Zhang E Koivunen MW Radomski ST Davidge 2000 Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction Circ Res 87 670 676
19. RF Gerlach AP de Souza JA Cury SR Line 2000 Effect of lead, cadmium and zinc on the activity of enamel matrix proteinases in vitro Eur J Oral Sci 108 327 334
20. Hao L, Du M, Lopez-Campistrous A, Fernandez-Patron C (2004) Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway. Circ Res 94(1):68-76. Epub 2003 Dec 1
21. Jurczuk M, Moniuszko-Jakoniuk J, Brzoska MM (2006) Involvement of some low-molecular thiols in the peroxidative mechanisms of lead and ethanol action on rat liver and kidney. Toxicology 219:11-21. Epub 2005 Dec 2002
22. G Karimi A Khoshbaten M Abdollahi M Sharifzadeh K Namiranian AR Dehpour 2002 Effects of subacute lead acetate administration on nitric oxide and cyclooxygenase pathways in rat isolated aortic ring Pharmacol Res 46 31 37 (Pubitemid 35300790)
23. S Kasperczyk M Dziwisz A Kasperczyk E Birkner 2002 Influence of lead exposure on arterial hypertension Wiad Lek 55 Suppl 1 230 234
24. F Khalil-Manesh HC Gonick EW Weiler B Prins MA Weber RE Purdy 1993 Lead-induced hypertension: possible role of endothelial factors Am J Hypertens 6 723 729 (Pubitemid 23290740)
25. Lahat N Fau, Shapiro S, Froom P, Kristal-Boneh E, Inspector M, Miller A (2002) Inorganic lead enhances cytokine-induced elevation of matrix metalloproteinase MMP-9 expression in glial cells. J Neuroimmunol 132(1-2):123-128
26. S Lehoux CA Lemarie B Esposito HR Lijnen A Tedgui 2004 Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling Circulation 109 1041 1047 (Pubitemid 38282859)
27. EC Lima F Barbosa Jr FJ Krug 2001 Lead determination in slurries of biological materials by ETAAS using a W-Rh permanent modifier Fresenius J Anal Chem 369 496 501 (Pubitemid 33751844)
28. JR Lynch R Blessing WD White HP Grocott MF Newman DT Laskowitz 2004 Novel diagnostic test for acute stroke Stroke 35 57 63 (Pubitemid 38057590)
29. M Marques I Millas A Jimenez E Garcia-Colis JA Rodriguez-Feo S Velasco A Barrientos S Casado A Lopez-Farre 2001 Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats J Am Soc Nephrol 12 2594 2600 (Pubitemid 33115405)
30. D Martin TA Glass K Bandeen-Roche AC Todd W Shi BS Schwartz 2006 Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults Am J Epidemiol 163 467 478
31. A Martinez HR Oh EJ Unsworth C Bregonzio JM Saavedra WG Stetler-Stevenson F Cuttitta 2004 Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator Biochem J 383 413 418 (Pubitemid 39546110)
32. KK Nelson JA Melendez 2004 Mitochondrial redox control of matrix metalloproteinases Free Radic Biol Med 37 768 784 (Pubitemid 39078549)
33. JS Neuberger M Mulhall MC Pomatto J Sheverbush RS Hassanein 1990 Health problems in Galena, Kansas: a heavy metal mining Superfund site Sci Total Environ 94 261 272 (Pubitemid 20200769)
34. RE Purdy JR Smith Y Ding F Oveisi ND Vaziri HC Gonick 1997 Lead-induced hypertension is not associated with altered vascular reactivity in vitro Am J Hypertens 10 997 1003 (Pubitemid 27428381)
35. HJ Ra WC Parks 2007 Control of matrix metalloproteinase catalytic activity Matrix Biol 26 587 596 (Pubitemid 350180394)
36. ME Ryan A Usman NS Ramamurthy LM Golub RA Greenwald 2001 Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity Curr Med Chem 8 305 316 (Pubitemid 32409782)
37. QX Sang WG Stetler-Stevenson LA Liotta SW Byers 1990 Identification of type IV collagenase in rat testicular cell culture: influence of peritubular-Sertoli cell interactions Biol Reprod 43 6 956 964
38. R Schulz 2007 Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches Annu Rev Pharmacol Toxicol 47 211 242 (Pubitemid 46272129)
39. SA Shelkovnikov HC Gonick 2001 Influence of lead on rat thoracic aorta contraction and relaxation Am J Hypertens 14 873 878 (Pubitemid 32862586)
40. A Skoczynska J Wrobel R Andrzejak 2001 Lead-cadmium interaction effect on the responsiveness of rat mesenteric vessels to norepinephrine and angiotensin II Toxicology 162 157 170 (Pubitemid 32706668)
41. CD Souza-Tarla JA Uzuelli AA Machado RF Gerlach JE Tanus-Santos 2005 Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities Clin Biochem 38 410 414 (Pubitemid 40501523)
42. GP Stricklin JJ Jeffrey WT Roswit AZ Eisen 1983 Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin Biochemistry 22 61 68 (Pubitemid 13154149)
43. MH Tayebjee S Nadar AD Blann D Gareth Beevers RJ MacFadyen GY Lip 2004 Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Am J Hypertens 17 764 769 (Pubitemid 39201090)
44. DA Tsao HS Yu JT Cheng CK Ho HR Chang 2000 The change of beta-adrenergic system in lead-induced hypertension Toxicol Appl Pharmacol 164 127 133 (Pubitemid 30238531)
45. HE Van Wart H Birkedal-Hansen 1990 The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family Proc Natl Acad Sci USA 87 5578 5582 (Pubitemid 20260224)
46. ND Vaziri Y Ding 2001 Effect of lead on nitric oxide synthase expression in coronary endothelial cells: role of superoxide Hypertension 37 223 226 (Pubitemid 32199078)
47. ND Vaziri Y Ding Z Ni HC Gonick 1997 Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy Kidney Int 52 1042 1046 (Pubitemid 27435837)
48. ND Vaziri Y Ding Z Ni 2001 Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug J Pharmacol Exp Ther 298 679 685 (Pubitemid 32673420)
49. R Visse H Nagase 2003 Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 827 839 (Pubitemid 36542523)
50. A Walter N Etienne-Selloum M Sarr MO Kane A Beretz VB Schini-Kerth 2008 Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols J Vasc Res 45 386 394
51. SW Watts C Rondelli K Thakali X Li B Uhal MH Pervaiz RE Watson GD Fink 2007 Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats Am J Physiol Heart Circ Physiol 292 H2438 H2448 (Pubitemid 47084627)
52. RC Webb RJ Winquist W Victery AJ Vander 1981 In vivo and in vitro effects of lead on vascular reactivity in rats Am J Physiol 241 H211 H216 (Pubitemid 11034602)
53. Winneke G (1986) Animal studies. In: Lead toxicity, history and environmental impact. Landsdown R, Yule W (eds) The Johns Hopkins University Press, Baltimore, pp 217-233
54. JF Woessner Jr 1991 Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J 5 2145 2154 (Pubitemid 21905847)
55. Yasmin, McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR, Wilkinson IB (2005) Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 25:372
56. Y Zhou RA Zanao F Barbosa PJ Parsons FJ Krug 2002 Investigations on a W-Rh permanent modifier for the detection of Pb in blood by electrothermal atomic absorption spectrometry Spectrochim Acta Part B 57 1291 1300 (Pubitemid 34413256)